المؤلفون: Fernandez-Sojo J; Advanced & Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain.; Transfusion Medicine Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain., Valdivia E; Advanced & Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain., Esquirol A; Adult Haematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and Jose Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain., Portos JM; Adult Haematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and Jose Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain., Rovira M; BMT Unit, Haematology Department, Hospital Clínic, IDIBAPS, University of Barcelona, Josep Carreras Foundation and Leukaemia Research Institute, Barcelona, Spain., Suarez M; BMT Unit, Haematology Department, Hospital Clínic, IDIBAPS, University of Barcelona, Josep Carreras Foundation and Leukaemia Research Institute, Barcelona, Spain., Diaz-de-Heredia C; Paediatric Oncology and Haematology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain., Uría ML; Paediatric Oncology and Haematology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain., Ortí G; Adult Haematology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Ferra C; Adult Haematology Department, Institut Català d'Oncologia-Badalona, Barcelona, Spain., Mussetti A; Adult Haematology Department, Institut Catala d'Oncologia-Hospitalet, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Paviglianiti A; Adult Haematology Department, Institut Catala d'Oncologia-Hospitalet, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Marsal J; Paediatric SCT Unit, Haematology Department, Hospital Sant Joan de Déu, Barcelona, Spain., Badell I; Paediatric Haematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Lozano M; Apheresis & Cellular Therapy Unit, Department of Haemotherapy and Haemostasis ICMHO, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain., Gomez D; Advanced & Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain., Azqueta C; Advanced & Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain., Martorell L; Advanced & Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain., Rubio N; Advanced & Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain., Garcia-Buendia A; Statistical Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain., Villa J; Spanish Bone Marrow Donor Registry, Josep Carreras Foundation and Leukaemia Research Institute, Barcelona, Spain., Carreras E; Spanish Bone Marrow Donor Registry, Josep Carreras Foundation and Leukaemia Research Institute, Barcelona, Spain., Querol S; Advanced & Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain.

المصدر: Vox sanguinis [Vox Sang] 2023 Sep; Vol. 118 (9), pp. 783-789. Date of Electronic Publication: 2023 Aug 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Science Country of Publication: England NLM ID: 0413606 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0410 (Electronic) Linking ISSN: 00429007 NLM ISO Abbreviation: Vox Sang Subsets: MEDLINE

مواضيع طبية MeSH: Bone Marrow Transplantation*/methods , Hematopoietic Stem Cell Transplantation*, Humans ; Bone Marrow ; Transplantation, Homologous ; Tissue Donors

المؤلفون: Panesso M; Division of Pediatric Oncology and Haematology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Institut de Recerca Vall d'Hebron, Barcelona, Spain., Uría ML; Division of Pediatric Oncology and Haematology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Institut de Recerca Vall d'Hebron, Barcelona, Spain., Renedo B; Institut de Recerca Vall d'Hebron, Barcelona, Spain.; Pharmacy Division, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Esperalba J; Institut de Recerca Vall d'Hebron, Barcelona, Spain.; Microbiology Division, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Benítez-Carabante MI; Division of Pediatric Oncology and Haematology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Institut de Recerca Vall d'Hebron, Barcelona, Spain., Mendoza-Palomar N; Institut de Recerca Vall d'Hebron, Barcelona, Spain.; Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Alonso L; Division of Pediatric Oncology and Haematology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Institut de Recerca Vall d'Hebron, Barcelona, Spain., Oliveras M; Institut de Recerca Vall d'Hebron, Barcelona, Spain.; Pharmacy Division, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Diaz-de-Heredia C; Division of Pediatric Oncology and Haematology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Institut de Recerca Vall d'Hebron, Barcelona, Spain.

المصدر: Frontiers in pediatrics [Front Pediatr] 2023 Jul 24; Vol. 11, pp. 1197828. Date of Electronic Publication: 2023 Jul 24 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101615492 Publication Model: eCollection Cited Medium: Print ISSN: 2296-2360 (Print) Linking ISSN: 22962360 NLM ISO Abbreviation: Front Pediatr Subsets: PubMed not MEDLINE

المؤلفون: Mozo Y; Pediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain., Bueno D; Pediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain., Sisinni L; Pediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain., Fernández-Arroyo A; Pediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain., Rosich B; Pediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain., Martínez AP; Pediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain., Benítez-Carabante MI; Pediatric Hemato-Oncology Department, Hospital Universitari Vall d´Hebron, Barcelona, Spain., Alonso L; Pediatric Hemato-Oncology Department, Hospital Universitari Vall d´Hebron, Barcelona, Spain., Uría ML; Pediatric Hemato-Oncology Department, Hospital Universitari Vall d´Hebron, Barcelona, Spain., Heredia CD; Pediatric Hemato-Oncology Department, Hospital Universitari Vall d´Hebron, Barcelona, Spain., Mestre-Duran C; Traslational Research Group in Pediatric Hemato-Oncology, Transplantation and Cell Therapy, Hospital La Paz Institute for Health Research, Madrid, Spain., Pascual CFB; Traslational Research Group in Pediatric Hemato-Oncology, Transplantation and Cell Therapy, Hospital La Paz Institute for Health Research, Madrid, Spain., Torres J; Immunology Department, La Paz University Hospital, Madrid, Spain., Losantos I; Statistic Department, La Paz University Hospital, Madrid Spain., Escudero A; Translational Research in Pediatric Oncology, Hematopoietic Transplantation & Cell Therapy, Hospital La Paz Institute for Health Research (INGEMM-IdiPAZ), Institute of Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Madrid, Spain., Ruz-Caracuel B; Translational Research in Pediatric Oncology, Hematopoietic Transplantation & Cell Therapy, Hospital La Paz Institute for Health Research (INGEMM-IdiPAZ), Institute of Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Madrid, Spain.

المصدر: Pediatric hematology and oncology [Pediatr Hematol Oncol] 2021 May; Vol. 38 (4), pp. 331-345. Date of Electronic Publication: 2021 Mar 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8700164 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0669 (Electronic) Linking ISSN: 08880018 NLM ISO Abbreviation: Pediatr Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease/*drug therapy , Hematopoietic Stem Cell Transplantation/*adverse effects , Protein Kinase Inhibitors/*therapeutic use , Pyrazoles/*therapeutic use, Adolescent ; Child ; Child, Preschool ; Female ; Graft vs Host Disease/etiology ; Humans ; Infant ; Janus Kinases/antagonists & inhibitors ; Male ; Nitriles ; Protein Kinase Inhibitors/adverse effects ; Pyrazoles/adverse effects ; Pyrimidines ; Retrospective Studies ; Treatment Outcome